Early 2026 NBA mock drafts project three former Mr. Indiana Basketball winners to be selected. The three prospects are Braden Smith, Flory Bidunga, and Braylon Mullins. Mock drafts from various ...

Brepocitinib is a first-in-class, oral, selective TYK2–JAK1 inhibitor that blocks cytokine signaling, which has been implicated in dermatomyositis. In this phase 3, double-blind, randomized, ...

It's officially NCAA Tournament time. The first round of the 2026 NCAA Men's Basketball Tournament is set to begin on Thursday, with 16 games followed by 16 more on Friday. It's going to be an epic ...

David Dastmalchian as Mr. 3 holding up a teacup in One Piece season 2 - Netflix At this point in its run, not much could possibly come as a surprise on Netflix's live-action "One Piece" adaptation.

China's BCI market estimated to reach $809 million by 2027 China expanding clinical trials, state support for BCIs Aims to close gap between research, industry and clinic BEIJING, March 8 (Reuters) - ...

A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77% crash in the biotech’s share price. The company has paused ...

Watching a Rom-Com this Valentine's Day? Before you get swept away, let's talk about the science of love vs. the magic of Hollywood. Watching a Rom-Com this Valentine's Day? Before you get swept away, ...

"So you need monsters for your movie? I know the scariest monsters!" Universal has unveiled the first full, official trailer for the new Minions movie titled officially Minions & Monsters. This is ...

Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...

Harkening back to the earlier era of video games and the popularity of the Boomer-shooter subgenre, Mr Donald is a satirical take on current world affairs and the gaming industry as a whole. While the ...

Trials aim to optimize frontline therapies for CLL, multiple myeloma, SLL, and pediatric acute leukemia/MDS, focusing on high-risk, treatment-naïve patients. Investigations include BTK inhibitors, CAR ...